DIABETES RESEARCH INSTITUTE FOUNDATION INC
Mission Statement
The mission of the Diabetes Research Institute Foundation is to provide the Diabetes Research Institute with the funding necessary to cure diabetes now. The mission of the Diabetes Research Institute is to develop and rapidly apply the most promising research to treat and cure those now living with diabetes. The DRI’s goals in support of its mission are: •Fostering a dynamic, multidisciplinary research team comprised of basic and clinical scientists that conduct innovative diabetes research. •Facilitating the translation of new research findings into novel therapies for patients with diabetes as quickly as possible. •Improving clinical care and enhancing the quality of life for all patients with diabetes through professional training and education programs. •Expanding collaborative alliances with other leading centers of research, thus creating a global intellectual environment, which streamlines research efforts worldwide and furthers our mission to cure diabetes. •Establishing corporate, philanthropic, and academic partnerships to share in the costs of research and development, thus accelerating the testing of new approaches and developments to cure diabetes.
Financial Overview — FY 2023
Compared with Peers
FY 2023| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
59.8% | 82.7% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
17.9% | 13.5% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
22.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
51.4% | 639.6% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
28.4 mo | 12.6 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.8% | 29.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
45.8% | 91.9% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-37.9% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-3.2% | 10.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-62.1% | -2.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $7.1M | $11.6M | $27.4M | 59.8% | 33 |
| 2022 | $11.5M | $11.9M | $30.9M | 61.4% | 34 |
| 2021 | $13.9M | $13.7M | N/A | — | 34 |
Donor Reviews
Write a ReviewBe the first to share your experience with this organization.